# Syed T. Husain

> Syed T. Husain is the Chairman and CEO of Made Scientific, a Princeton, New Jersey cell therapy contract development and manufacturing organization (CDMO) that he relaunched in 2025 out of the former BioCentriq. Backed by GC Corporation, the company runs a 60,000-square-foot GMP facility built to move autologous and allogeneic cell therapies from clinical batches to commercial supply. A chemical engineer by training who started on the manufacturing floor at Wyeth and Pfizer, Husain spent more than two decades in CDMO leadership at Lonza, Alcami, Emergent BioSolutions, and Resilience before taking the top job. He named the rebranded company MADE for Manufacturing and Development Excellence.

- **Role:** Chairman and Chief Executive Officer at Made Scientific
- **Organizations:** Made Scientific, GC Corporation, New Jersey Institute of Technology (Industrial Advisory Board), Drug, Chemical & Associated Technologies Association (DCAT)
- **Education:** MBA, Cornell University, Johnson Graduate School of Management, B.S., Chemical Engineering, New Jersey Institute of Technology
- **Known for:** Relaunched BioCentriq as Made Scientific, a GC Corporation-backed cell therapy CDMO, Opened a 60,000 sq ft purpose-built GMP cell therapy facility and headquarters in Princeton, NJ, At Resilience, built a commercial organization spanning multiple modalities with a multi-billion-dollar opportunity pipeline

## Career timeline

- **early career** — Manufacturing compliance at Wyeth
- **—** — Advanced through validation, product development, and manufacturing leadership at Pfizer
- **—** — Senior leadership roles at Lonza
- **—** — Commercial strategy and operations at Alcami Corporation
- **—** — Strategic leadership at Emergent BioSolutions
- **—** — Chief Commercial Officer at Resilience, building a commercial organization across biologics, vaccines, cell & gene therapy, and nucleic acids
- **2024** — Appointed CEO and board member of BioCentriq (September 19, 2024)
- **2025** — Led rebrand of BioCentriq to Made Scientific and became Chairman & CEO
- **2026** — Expanded Made Scientific's board and celebrated grand opening of the Princeton GMP facility

## Achievements

- Relaunched BioCentriq as Made Scientific, a GC Corporation-backed cell therapy CDMO
- Opened a 60,000 sq ft purpose-built GMP cell therapy facility and headquarters in Princeton, NJ
- At Resilience, built a commercial organization spanning multiple modalities with a multi-billion-dollar opportunity pipeline
- Assembled a Made Scientific board with more than a century of combined CDMO and pharma leadership
- Serves on the Industrial Advisory Board of NJIT and chairs the Education Committee of DCAT
- Signed strategic manufacturing partnerships with Sentinel BioTherapeutics and Cytora Therapeutics

## Latest updates

- **2026-04** — Made Scientific strengthened its board with new directors Ted Dolan and Soyoung Park to support scale-up and commercial readiness.
- **2025** — BioCentriq rebranded as Made Scientific under Husain's leadership; company celebrated the grand opening of its Princeton GMP facility.

## Links

- Website: https://madescientific.com
- LinkedIn: http://www.linkedin.com/in/syedthusain

---

Profile page: https://yespress.io/syed-husain
Published by YesPress — https://yespress.io
Last updated: 2026-07-08